Sugi Predict

Sugi Predict / Compounds / SCHEMBL447473

SCHEMBL447473

SCHEMBL447473

Nc1ccc(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 4/20 0.48
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAOB P27338 2/20 0.36
▸ PTGS1 P23219 3/20 0.35
▸ MAPK1 P28482 3/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ TP53 P04637 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ TSHR P16473 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ TAAR1 Q96RJ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL486692 0.98 KIF11 (0.46) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL3871917 0.98 KIF11 (0.46) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL30891615 0.98 KIF11 (0.46) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL8176042 0.93 KIF11 (0.50) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL7080175 0.93 KIF11 (0.54) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL17817842 0.90 KIF11 (0.52) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL7076981 0.90 KIF11 (0.52) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL7078537 0.90 KIF11 (0.52) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL7072713 0.87 KIF11 (0.54) KIF11MAPTMEN1KMT2AALDH1A1
SCHEMBL673282 0.85 LMNA (0.43) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117999272-A Peptides ＡＧＣ株式会社 2024-05-07 — — CN disclosed
CN-117616032-A Rare earth complex 东曹株式会社 2024-02-27 — — CN disclosed
WO-2022261352-A1 PERFLUOROALKANE SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDIN AND PYRROLO[2,3-D]PYRIMIDIN COMPOUNDS AND USES THEREOF ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2022-12-15 — — WO disclosed
CN-110172122-B Preparation method of intelligent fabric finishing agent with switchable surface affinity and hydrophobicity 苏州大学 2021-07-09 — — CN disclosed
CN-109180857-B Intelligent fabric finishing liquid with convertible surface affinity and hydrophobicity 南通纺织丝绸产业技术研究院 2020-09-18 — — CN disclosed
CN-108912263-B Application of intelligent fabric finishing liquid with convertible surface hydrophilicity and hydrophobicity in fabric finishing 南通纺织丝绸产业技术研究院 2020-09-08 — — CN disclosed
CN-109134746-B Intelligent fabric and application thereof 苏州大学 2020-09-08 — — CN disclosed
US-8642624-B2 Substituted alkylamine derivatives and methods of use AMGEN INC. (US) 2014-02-04 — — US disclosed
US-20130273004-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2013-10-17 — — US disclosed
EP-1537084-B1 SUBSTITUTED 2-ALKYLAMINE NICOTINIC AMIDE DERIVATIVES AND USE THERE OF AMGEN INC (US) 2013-08-21 — — EP disclosed
WO-2004007458-A1 SUBSTITUTED 2-ALKYLAMINE NICOTINIC AMIDE DERIVATIVES AND USE THERE OF AMGEN INC. (US) 2004-01-22 — — WO disclosed
WO-2004007457-A2 SUBSTITUTED BENZYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2004-01-22 — — WO disclosed
US-20030225106-A1 Substituted alkylamine derivatives and methods of use AMGEN INC. 2003-12-04 — — US disclosed
EP-1358184-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2003-11-05 — — EP disclosed
US-20030203922-A1 Substituted amine derivatives and methods of use AMGEN INC. 2003-10-30 — — US disclosed
US-20030195230-A1 Substituted amine derivatives and methods of use AMGEN INC. 2003-10-16 — — US disclosed
US-20030125339-A1 Substituted alkylamine derivatives and methods of use AMGEN INC. 2003-07-03 — — US disclosed
WO-2002068406-A2 SUBSTITUTED AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF ANGIOGENESIS AMGEN INC. (US) 2002-09-06 — — WO disclosed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 — — WO disclosed
US-4731450-A Process for perfluoroalkylation of aromatic derivatives RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1988-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225106-A1 Substituted alkylamine derivatives and methods of use NAT1, PIGO, AADAC KIF11 4521/4885MAPT 4232/4885MEN1 846/4885
US-20030125339-A1 Substituted alkylamine derivatives and methods of use AADAC, NAT1, PIGO KIF11 4771/4885MAPT 4734/4885MEN1 1464/4885
US-20130273004-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AADAC, NAT1, PIGO KIF11 4770/4885MAPT 4726/4885MEN1 1584/4885
US-20030203922-A1 Substituted amine derivatives and methods of use MAOB, HNMT, FLT4 KIF11 3876/4885MAPT 2262/4885MEN1 664/4885
US-20030195230-A1 Substituted amine derivatives and methods of use MAOB, HNMT, FLT4 KIF11 3876/4885MAPT 2262/4885MEN1 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.